✦ LIBER ✦

Safety of atazanavir/ritonavir with tenofovir disoproxil fumarate in HIV-infected adolescents

✍ Scribed by Bunupuradah, T.; Techasaensiri, C.; Keadpudsa, S.; Srimuan, A.; Sahakijpicharn, T.; Sriheara, C.; Thammajaruk, N.; Prasitsuebsai, W.; Ananworanich, J.; Puthanakit, T.

Book ID: 124138611
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 72 KB
Volume: 21
Category: Article
ISSN: 1201-9712
DOI: 10.1016/j.ijid.2014.03.1034

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-Term Renal Safety of Tenofovir Diso

Long-Term Renal Safety of Tenofovir Disoproxil Fumarate in Vertically HIV-Infected Children, Adolescents and Young Adults

✍ Dr Alessandra Viganò, Giorgio Bedogni, Valeria Manfredini, Vania Giacomet, Chiar 📂 Article 📅 2011 🏛 Springer International Publishing AG 🌐 English ⚖ 139 KB

Renal function in HIV-infected children

Renal function in HIV-infected children and adolescents treated with tenofovir disoproxil fumarate and protease inhibitors

✍ Giuseppe Pontrelli; Nicola Cotugno; Donato Amodio; Paola Zangari; Hyppolite K Tc 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 314 KB

Systematic Review and Meta‐analysis: Ren

Systematic Review and Meta‐analysis: Renal Safety of Tenofovir Disoproxil Fumarate in HIV‐Infected Patients

✍ Cooper, Ryan D.; Wiebe, Natasha; Smith, Nathaniel; Keiser, Philip; Naicker, Sara 📂 Article 📅 2010 🏛 University of Chicago Press 🌐 English ⚖ 531 KB

Tenofovir disoproxil fumarate reduces HI

Tenofovir disoproxil fumarate reduces HIV RNA levels in treatment-experienced patients with HIV infection

📂 Article 📅 2001 🏛 Adis International Limited (now part of Wolters Kl ⚖ 151 KB

Co-formulated elvitegravir, cobicistat,

Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial

✍ Edwin DeJesus; Jürgen K Rockstroh; Keith Henry; Jean-Michel Molina; Joseph Gathe 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 339 KB

Anti-hepatitis B virus efficacy of tenof

Anti-hepatitis B virus efficacy of tenofovir disoproxil fumarate in HIV-infected patients

✍ Yves Benhamou; Herve Fleury; Pascale Trimoulet; Isabelle Pellegrin; Renaud Urbin 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB

for the TECOVIR Study Group Tenofovir disoproxil fumarate (TDF) has shown in vitro activity against both HIV and hepatitis B virus (HBV). We retrospectively evaluated the efficacy of TDF (300 mg/d), administered as a part of anti-retroviral therapy, in a large cohort of HIV/HBV-coinfected patients.